We are optimistic about the potential benefits of our stem cell therapy, yet we remain aware of the challenges that may arise. The primary concern centres around the long-term effectiveness of our approach. It will be essential to continuously monitor the integration of NPCs into the host brain tissue and assess their impact on recovery while minimizing side effects. For these cells to be effective, they must integrate seamlessly and establish stability within the brain. The positive results we hope to achieve will depend on the proper functioning and integration of these cells.

Moreover, while intracranial delivery is known for its efficacy, it presents unique challenges, including potential complications and the need for specialized surgical expertise. A significant hurdle affecting IC administration is the associated costs. Many patients may be unable to afford the necessary surgical interventions and post-operative care, limiting access to this potentially life-changing treatment

As the field of regenerative medicine evolves, we must closely monitor advancements in new delivery systems anticipated to emerge over the next decade. Innovations in techniques or technologies that are less invasive and more cost-effective could lead to improved patient outcomes and wider accessibility of our therapy. Staying aware of these developments will be crucial as we navigate the landscape of potential challenges.

Our primary focus remains on treating stroke patients, but our therapy also holds promise for adaptation to other neurological disorders. By leveraging the expertise gained from ongoing studies and clinical trials, we aim to expand the applications of our NPCs in addressing diseases of the central nervous system. This vision involves establishing new partnerships with research institutions and medical providers to collaboratively explore new applications while addressing the challenges posed by emerging technologies and ATMPs.

We anticipate that by overcoming these obstacles, we can enhance the treatment of neurological disorders and significantly improve the quality of life for a greater number of patients. Our commitment to advancing stroke treatment, while also exploring broader neurological applications, positions our therapy as a beacon of hope for patients facing these complex challenges.